U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07779915) titled 'MICropsampling for CAffeine in PREMature Newborns' on Aug. 13.
Brief Summary: Caffeine is one of the top five most prescribed drugs in neonatology. Caffeine has many beneficial impacts on preterm infants (cardiac, neurologic and pulmonary). One of these beneficial impacts is to prevent apnea. However, despite its use in routine neonatal practice, there is currently no consensus on standardized protocols for caffeine administration concerning timing and dose and there is a lack of knowledge in the most immature preterm. High caffeine concentrations may lead to serious adverse events such tachycardia while low caffeine concentrations ...